How Will Our Practice Change After the CLEAR Outcomes Trial?

"Declarations Conflict of InterestS.J.N. has received research support from AstraZeneca, Amgen, Anthera, CSL Behring, Cerenis, Eli Lilly, Resverlogix, New Amsterdam Pharma, Novartis, InfraReDx and Sanofi-Regeneron. S.J.N. is also a consultant for Amgen, Akcea, AstraZeneca, Boehringer Ingelheim, CSL Behring, Eli Lilly, Esperion, Kowa, Merck, Takeda, Pfizer, Sanofi- Regeneron, Vaxxinity, CSL Sequiris, and Novo Nordisk. S.J.N. also reports grants and personal fees from Esperion. A.J.N. has received research support and consulting fees from Amgen and Novartis. T.A. has no relationships to disclose. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest S.J.N. has received research support from AstraZeneca, Amgen, Anthera, CSL Behring, Cerenis, Eli Lilly, Resverlogix, New Amsterdam Pharma, Novartis, InfraReDx and Sanofi-Regeneron. S.J.N. is also a consultant for Amgen, Akcea, AstraZeneca, Boehringer Ingelheim, CSL Behring, Eli Lilly, Esperion, Kowa, Merck, Takeda, Pfizer, Sanofi- Regeneron, Vaxxinity, CSL Sequiris, and Novo Nordisk. S.J.N. also reports grants and personal fees from Esperion. A.J.N. has received research support and consulting fees from Amgen and Novartis. T.A. has no relationships to disclose."

"Funding Open Access funding enabled and organized by CAUL and its Member Institutions"